Freshford Capital Management, LLC Bausch & Lomb Corp Transaction History

Freshford Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.6 - $17.06 $13.5 Million - $17 Million	-995,004 Reduced 85.39%	170,276 $2.47 Million
Q1 2024 May 15, 2024	SELL	$13.68 - $17.6 $8.06 Million - $10.4 Million	-588,843 Reduced 33.57%	1,165,280 $20.2 Million
Q4 2023 Feb 14, 2024	BUY	$14.87 - $17.56 $5.99 Million - $7.08 Million	403,062 Added 29.83%	1,754,123 $29.9 Million
Q3 2023 Nov 14, 2023	BUY	$16.8 - $20.99 $6.39 Million - $7.98 Million	380,132 Added 39.15%	1,351,061 $22.9 Million
Q2 2023 Aug 14, 2023	BUY	$16.03 - $20.07 $15.6 Million - $19.5 Million	970,929 New	970,929 $19.5 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Freshford Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Freshford Capital Management, LLC with notifications on news.